These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1351384)

  • 1. [C-erb B-2 protein in the sera of breast cancer patients].
    Narita T; Funahashi H; Satoh Y; Takagi H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):909-11. PubMed ID: 1351384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of sandwich radioimmunometric assay for serum c-erbB-2 oncogene product and its significance in diagnosing breast carcinoma].
    Yu FZ; Sugano K; Ohkura H; Mori S
    Rinsho Byori; 1991 Oct; 39(10):1087-92. PubMed ID: 1684826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
    Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
    Anticancer Res; 1991; 11(5):1677-81. PubMed ID: 1685075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH; Leslie KO; Rogers LA; Howard PL
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.
    Bhatavdekar JM; Patel DD; Sherbet GV; Giri DD; Karelia NH; Vora HH; Shah NG; Suthar TP; Nadkarni SP; Balar DB
    Eur J Surg Oncol; 1993 Oct; 19(5):409-13. PubMed ID: 8104829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of C-erbB-2 protein in breast cancer tissue by enzyme-immunoassay: preliminary report].
    Narita T; Funahashi H; Sato Y; Imai T; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):661. PubMed ID: 8101962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytosolic oncogenic neu protein determined with enzyme immunoassay: approximation to a marker of clinical application].
    Allende MT; Fernández Fernández M; Fernández Llana B; Ruibal A
    Rev Clin Esp; 1992 Oct; 191(6):334-5. PubMed ID: 1361681
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G; Maesawa C; Mikawa S; Satodate R
    Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
    J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absence of correlation between morphometric parameters and C-erb-B2 positivity].
    Leopardi O; Colavecchio A; Colecchia M; Cannatelli G
    Pathologica; 1992; 84(1094):83-5. PubMed ID: 1363760
    [No Abstract]   [Full Text] [Related]  

  • 13. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of c-erbB-2 protein in patients with lung adenocarcinoma: preliminary report].
    Ohsaki T; Mitsudomi T; Oyama T; Kodate M; Nakanishi R; Shirakusa T
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):320. PubMed ID: 8100349
    [No Abstract]   [Full Text] [Related]  

  • 17. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.
    Tsuda H; Tsugane S; Fukutomi T; Nanasawa T; Yamamoto H; Hirohashi S
    Jpn J Clin Oncol; 1992 Aug; 22(4):244-9. PubMed ID: 1359174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in breast carcinoma with special reference to the C-erb-B2 gene: preliminary results].
    Criscuolo M; Federico M; Sabbatini R; Rossi E; Piccinini L; Trentini GP
    Pathologica; 1992; 84(1094):87-91. PubMed ID: 1363761
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.